{"id":5669,"date":"2006-07-06T09:45:00","date_gmt":"2006-07-06T09:45:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&p=5669"},"modified":"2021-07-09T11:15:01","modified_gmt":"2021-07-09T11:15:01","slug":"granulocytapheresis-gcap-for-severe-alcoholic-hepatitis-a-preliminary-report","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/fr\/professional\/scientific-corner\/granulocytapheresis-gcap-for-severe-alcoholic-hepatitis-a-preliminary-report\/","title":{"rendered":"Granulocytapheresis (GCAP) for severe alcoholic hepatitis-A preliminary report"},"content":{"rendered":"
\n

Ryukichi Kumashiro<\/a> 1<\/a><\/sup>, Yuriko Koga<\/a>, Reiichirou Kuwahara<\/a>, Tatsuya Ide<\/a>, Teruko Hino<\/a>, Kazuo Tanaka<\/a>, Akiko Hisamochi<\/a>, Kei Ogata<\/a>, Yukari Takao<\/a>, Hiroyuki Koga<\/a>, Hidemi Nishida<\/a>, Seiya Okuda<\/a>, Teruo Sakamoto<\/a>, Michio Sata<\/a>, Hepatol Res. 2006 Nov;36(3):229-36.<\/p>\n<\/div>\n\n

\n

GCAP therapy deserves further evaluation as a new therapeutic modality for a moderately severe alcoholic hepatitis.<\/p>\n<\/div>\n\n

\n

https:\/\/pubmed.ncbi.nlm.nih.gov\/16949861\/<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

Ryukichi Kumashiro 1, Yuriko Koga, Reiichirou Kuwahara, Tatsuya Ide, Teruko Hino, Kazuo Tanaka, Akiko Hisamochi, Kei Ogata, Yukari Takao, Hiroyuki Koga, Hidemi Nishida, Seiya Okuda, Teruo Sakamoto, Michio Sata, Hepatol Res. 2006 Nov;36(3):229-36. GCAP therapy deserves further evaluation as a new therapeutic modality for a moderately severe alcoholic hepatitis. https:\/\/pubmed.ncbi.nlm.nih.gov\/16949861\/<\/p>\n","protected":false},"template":"","scientific_tags":[314],"class_list":["post-5669","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-digestive"],"acf":[],"yoast_head":"\nGranulocytapheresis (GCAP) for severe alcoholic hepatitis-A preliminary report - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocytapheresis-gcap-for-severe-alcoholic-hepatitis-a-preliminary-report\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Granulocytapheresis (GCAP) for severe alcoholic hepatitis-A preliminary report - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Ryukichi Kumashiro 1, Yuriko Koga, Reiichirou Kuwahara, Tatsuya Ide, Teruko Hino, Kazuo Tanaka, Akiko Hisamochi, Kei Ogata, Yukari Takao, Hiroyuki Koga, Hidemi Nishida, Seiya Okuda, Teruo Sakamoto, Michio Sata, Hepatol Res. 2006 Nov;36(3):229-36. GCAP therapy deserves further evaluation as a new therapeutic modality for a moderately severe alcoholic hepatitis. https:\/\/pubmed.ncbi.nlm.nih.gov\/16949861\/\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocytapheresis-gcap-for-severe-alcoholic-hepatitis-a-preliminary-report\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-09T11:15:01+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocytapheresis-gcap-for-severe-alcoholic-hepatitis-a-preliminary-report\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocytapheresis-gcap-for-severe-alcoholic-hepatitis-a-preliminary-report\/\",\"name\":\"Granulocytapheresis (GCAP) for severe alcoholic hepatitis-A preliminary report - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2006-07-06T09:45:00+00:00\",\"dateModified\":\"2021-07-09T11:15:01+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocytapheresis-gcap-for-severe-alcoholic-hepatitis-a-preliminary-report\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Granulocytapheresis (GCAP) for severe alcoholic hepatitis-A preliminary report - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocytapheresis-gcap-for-severe-alcoholic-hepatitis-a-preliminary-report\/","og_locale":"fr_FR","og_type":"article","og_title":"Granulocytapheresis (GCAP) for severe alcoholic hepatitis-A preliminary report - Adacyte","og_description":"Ryukichi Kumashiro 1, Yuriko Koga, Reiichirou Kuwahara, Tatsuya Ide, Teruko Hino, Kazuo Tanaka, Akiko Hisamochi, Kei Ogata, Yukari Takao, Hiroyuki Koga, Hidemi Nishida, Seiya Okuda, Teruo Sakamoto, Michio Sata, Hepatol Res. 2006 Nov;36(3):229-36. GCAP therapy deserves further evaluation as a new therapeutic modality for a moderately severe alcoholic hepatitis. https:\/\/pubmed.ncbi.nlm.nih.gov\/16949861\/","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocytapheresis-gcap-for-severe-alcoholic-hepatitis-a-preliminary-report\/","og_site_name":"Adacyte","article_modified_time":"2021-07-09T11:15:01+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocytapheresis-gcap-for-severe-alcoholic-hepatitis-a-preliminary-report\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocytapheresis-gcap-for-severe-alcoholic-hepatitis-a-preliminary-report\/","name":"Granulocytapheresis (GCAP) for severe alcoholic hepatitis-A preliminary report - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2006-07-06T09:45:00+00:00","dateModified":"2021-07-09T11:15:01+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocytapheresis-gcap-for-severe-alcoholic-hepatitis-a-preliminary-report\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific-corner\/5669","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/media?parent=5669"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific_tags?post=5669"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}